Literature DB >> 16053141

Nanobodies.

W Wayt Gibbs.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16053141     DOI： 10.1038/scientificamerican0805-78

Source DB:  PubMed          Journal:  Sci Am        ISSN： 0036-8733            Impact factor:   2.142


× No keyword cloud information.
  10 in total

1.  Stepwise engineering of heterodimeric single domain camelid VHH antibodies that passively protect mice from ricin toxin.

Authors:  David J Vance; Jacqueline M Tremblay; Nicholas J Mantis; Charles B Shoemaker
Journal:  J Biol Chem       Date:  2013-11-07       Impact factor: 5.157

2.  Camelid nanobodies with high affinity for broad bean mottle virus: a possible promising tool to immunomodulate plant resistance against viruses.

Authors:  Ahmed Ghannam; Safa Kumari; Serge Muyldermans; Abdul Qader Abbady
Journal:  Plant Mol Biol       Date:  2015-02-04       Impact factor: 4.076

3.  Camelid single domain antibodies (VHHs) as neuronal cell intrabody binding agents and inhibitors of Clostridium botulinum neurotoxin (BoNT) proteases.

Authors:  Jacqueline M Tremblay; Chueh-Ling Kuo; Claudia Abeijon; Jorge Sepulveda; George Oyler; Xuebo Hu; Moonsoo M Jin; Charles B Shoemaker
Journal:  Toxicon       Date:  2010-07-14       Impact factor: 3.033

4.  Alpaca (Lama pacos) as a convenient source of recombinant camelid heavy chain antibodies (VHHs).

Authors:  David R Maass; Jorge Sepulveda; Anton Pernthaner; Charles B Shoemaker
Journal:  J Immunol Methods       Date:  2007-05-15       Impact factor: 2.303

5.  A single VHH-based toxin-neutralizing agent and an effector antibody protect mice against challenge with Shiga toxins 1 and 2.

Authors:  Jacqueline M Tremblay; Jean Mukherjee; Clinton E Leysath; Michelle Debatis; Kwasi Ofori; Karen Baldwin; Courtney Boucher; Rachel Peters; Gillian Beamer; Abhineet Sheoran; Daniela Bedenice; Saul Tzipori; Charles B Shoemaker
Journal:  Infect Immun       Date:  2013-09-30       Impact factor: 3.441

Review 6.  Nanoparticles approaches in neurodegenerative diseases diagnosis and treatment.

Authors:  Zahra Asefy; Sirus Hoseinnejhad; Zaker Ceferov
Journal:  Neurol Sci       Date:  2021-04-12       Impact factor: 3.307

7.  Accelerated neuronal cell recovery from Botulinum neurotoxin intoxication by targeted ubiquitination.

Authors:  Chueh-Ling Kuo; George A Oyler; Charles B Shoemaker
Journal:  PLoS One       Date:  2011-05-24       Impact factor: 3.240

8.  A novel strategy for development of recombinant antitoxin therapeutics tested in a mouse botulism model.

Authors:  Jean Mukherjee; Jacqueline M Tremblay; Clinton E Leysath; Kwasi Ofori; Karen Baldwin; Xiaochuan Feng; Daniela Bedenice; Robert P Webb; Patrick M Wright; Leonard A Smith; Saul Tzipori; Charles B Shoemaker
Journal:  PLoS One       Date:  2012-01-06       Impact factor: 3.240

Review 9.  Immunodiagnosis of neurocysticercosis: ways to focus on the challenge.

Authors:  M Esquivel-Velázquez; P Ostoa-Saloma; J Morales-Montor; R Hernández-Bello; C Larralde
Journal:  J Biomed Biotechnol       Date:  2011-10-29

10.  Single domain antibodies against enteric pathogen virulence factors are active as curli fiber fusions on probiotic E. coli Nissle 1917.

Authors:  Ilia Gelfat; Yousuf Aqeel; Jacqueline M Tremblay; Justyna J Jaskiewicz; Anishma Shrestha; James N Lee; Shenglan Hu; Xi Qian; Loranne Magoun; Abhineet Sheoran; Daniela Bedenice; Colter Giem; Avinash Manjula-Basavanna; Amanda R Pulsifer; Hann X Tu; Xiaoli Li; Marilyn L Minus; Marcia S Osburne; Saul Tzipori; Charles B Shoemaker; John M Leong; Neel S Joshi
Journal:  PLoS Pathog       Date:  2022-09-15       Impact factor: 7.464
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.